Target intelligence / Profile preview

Heme (ferrous protoporphyrin IX) (None (commonly referred to as "heme" or "Fe(II)-heme" for the ferrous form))

Target
None (commonly referred to as "heme" or "Fe(II)-heme" for the ferrous form)
Molecular classification
Other (porphyrin prosthetic group), Cofactor, Metalloprotein ligand component
01

Overview

Heme is a prosthetic group consisting of a protoporphyrin IX ring complexed with a central ferrous iron atom (Fe^2+^). It serves as a critical cofactor enabling oxygen transport in hemoglobin and myoglobin, electron transfer in cytochromes, and catalysis in a diverse range of enzymes (such as cytochrome P450s, peroxidases, and catalases). In its ferrous (Fe^2+^) state, heme can reversibly bind oxygen and other diatomic gases, enabling dynamic regulation of biological processes. The distinct redox and coordination chemistry of heme iron underlies its varied biological roles and makes it central to energy metabolism, oxidative defense, cellular signaling, and other processes. Defective heme synthesis or degradation contributes to diseases such as porphyrias, anemia, and certain toxicities. Free heme is highly reactive and potentially cytotoxic, emphasizing the need for tight physiological regulation. Note: "Heme/Ferrous Iron" is not a unique drug target but a foundational biochemical entity participating in the function of a vast array of biological proteins. Targeting heme or its metabolism affects a spectrum of pathways rather than a single molecular target.

Other names
Hemin (oxidized form, Fe^3+^)Ferroheme (heme with Fe^2+^, the biologically active form in oxygen binding)ProtohemeProtoporphyrin IX containing ferrous ironHeme b (the most common type in biology)
02

Mechanism of action

Drugs may provide hemin as a source to bypass heme synthetic blocks (e.g., in acute porphyria) Iron chelators reduce availability of ferrous iron for heme synthesis Induction or inhibition of heme-containing enzymes (e.g., cytochromes) alters drug metabolism

03

Biological functions

Oxygen transport (as part of hemoglobin and myoglobin)Electron transport (component of cytochromes in the electron transport chain)Enzymatic catalysis (in cytochromes, catalases, peroxidases, nitric oxide synthase, etc.)Signal transduction (regulation of circadian rhythm, microRNA processing)Cellular respirationCellular differentiation and proliferation
04

Disease associations

Anemia (when deficient)Porphyrias (inherited disorders of heme metabolism)Iron overload disordersOxidative stress-mediated injury (free heme is pro-oxidant)Infection (certain pathogens exploit or are affected by heme)
05

Safety considerations

Free heme is cytotoxic and pro-oxidant, causing cellular injury by generating reactive oxygen speciesAccumulation of free iron from heme degradation drives Fenton chemistry and oxidative stressDisrupted heme metabolism can result in porphyrias or anemiaHeme/iron overload may contribute to cardiovascular and neurodegenerative diseases
06

Interacting drugs

Hemin (therapeutic form used to treat certain porphyrias)

4 more in the full profile.

07

Biomarkers

Free heme or hemin levels (marker for hemolysis or oxidative stress)Total ironFerritin (storage form)Transferrin saturationPorphyrins (for porphyria diagnosis)

Beyond the preview

Go deeper on Heme (ferrous protoporphyrin IX) (None (commonly referred to as "heme" or "Fe(II)-heme" for the ferrous form)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heme (ferrous protoporphyrin IX) (None (commonly referred to as "heme" or "Fe(II)-heme" for the ferrous form)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call